NASDAQ:OVID

Ovid Therapeutics Stock Forecast

etoro logo Buy OVID
*Your capital is at risk
$2.36
+0.0100 (+0.426%)
At Close: Jul 28, 2026
AI Analysis AI Analysis of OVID AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add OVID to Watchlist?
Some Reasons Why To Add OVID:
  • +336.8% price growth over the last year
  • High gross margin of 99.5%
  • Lower volatility than the market (beta 0.19)
PDF

Ovid Therapeutics Inc stock price ended at $2.36 on Tuesday, after gaining 0.426%
(Updated on Jul 28, 2026)

Sell candidate since Jul 24, 2026 Gain 1.29%

The Ovid Therapeutics Inc stock price gained 0.426% on the last trading day (Tuesday, 28th Jul 2026), rising from $2.35 to $2.36. During the last trading day the stock fluctuated 6.70% from a day low at $2.24 to a day high of $2.39. The price has been going up and down for this period, and there has been a -4.07% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 160 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $2.85 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.40% during the next 3 months and, with a 90% probability hold a price between $1.84 and $2.40 at the end of this 3-month period.

OVID Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 20, 2026, and so far it has risen 2.39%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ovid Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.36 and $2.45. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Ovid Therapeutics Inc stock

Ovid Therapeutics Inc finds support from accumulated volume at $2.27 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.150 between high and low, or 6.70%. For the last week, the stock has had daily average volatility of 5.83%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (OVID) For The Upcoming Trading Day Of Wednesday 29th

For the upcoming trading day on Wednesday, 29th we expect Ovid Therapeutics Inc to open at $2.33, and during the day (based on 14 day Average True Range), to move between $2.28 and $2.44, which gives a possible trading interval of +/-$0.158 (+/-6.92%) up or down from last closing price. If Ovid Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 6.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.40 (1.69%) than the support at $2.27 (3.81%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Ovid Therapeutics Inc stock A Buy?

Ovid Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -3.642 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 29, 2026 - $2.33 ( 1.27%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

OVID Performance

Trading levels for OVID

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 2.48 5.08%
R2 2.42 2.66%
R1 2.39 1.16%
Price 2.36
S1 2.27 -3.70%
S2 2.24 -5.20%
S3 2.18 -7.63%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.55 8.05%
R2 2.42 2.54%
R1 2.40 1.69%
Price 2.36
S1 2.27 -3.81%
S2 2.25 -4.66%
S3 2.21 -6.36%

FAQ

What is the symbol for Ovid Therapeutics Inc Stock and on which exchange is it traded?
The symbol for Ovid Therapeutics Inc is OVID and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ovid Therapeutics Inc Stock?
Ovid Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Ovid Therapeutics Inc Stock?
Ovid Therapeutics Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ovid Therapeutics Inc Stock.

What's the current price of Ovid Therapeutics Inc Stock?
As of the end of day on the Jul 28, 2026, the price of an Ovid Therapeutics Inc (OVID) share was $2.36.

What is the 52-week high and low for Ovid Therapeutics Inc Stock?
The 52-week high for Ovid Therapeutics Inc Stock is $3.11 and the 52-week low is $0.475.

What is the market capitalization of Ovid Therapeutics Inc Stock?
As of the Jul 28, 2026, the market capitalization of Ovid Therapeutics Inc is 440.47M.

When is the next earnings date for Ovid Therapeutics Inc?
The upcoming earnings date for Ovid Therapeutics Inc is Aug 12, 2026.
Click to get the best stock tips daily for free!
ABOUT OVID THERAPEUTICS INC
Ovid Therapeutics
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment of seizures associated with tuberous sclerosis complex and infantile spasms; and OV350, a small molecule...
GOLDEN STAR
Ticker Change Signal Date
BIIB
$202.19
1.69% Jul 24
A
AVS
$7.74
0.388% Jul 24
IMMR
$6.60
16.06% Jul 23
S
SW
$43.71
16.22% Jul 23
TSCO
$30.32
3.76% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE